Index DJIA, NDX, S&P 500
P/E 26.95
EPS (ttm) 10.95
Insider Own 0.22%
Shs Outstand 537.70M
Perf Week -1.00%
Market Cap 158.77B
Forward P/E 13.75
EPS next Y 21.48
Insider Trans -6.53%
Shs Float 536.51M
Perf Month 0.63%
Enterprise Value 207.34B
PEG 6.28
EPS next Q 5.24
Inst Own 81.16%
Short Float 2.75%
Perf Quarter 1.44%
Income 5.93B
P/S 4.68
EPS this Y 5.11%
Inst Trans 3.43%
Short Ratio 5.25
Perf Half Y 12.67%
Sales 33.93B
P/B 25.58
EPS next Y 2.99%
ROA 6.51%
Short Interest 14.75M
Perf YTD 13.29%
Book/sh 11.54
P/C 18.02
EPS next 5Y 4.29%
ROE 105.67%
52W High 346.85 -14.87%
Perf Year -6.53%
Cash/sh 16.38
P/FCF 14.55
EPS past 3/5Y -9.75% -10.10%
ROIC 9.85%
52W Low 253.30 16.57%
Perf 3Y 20.40%
Dividend Est. 9.65 (3.27%)
EV/EBITDA 14.31
Sales past 3/5Y 8.54% 7.40%
Gross Margin 67.43%
Volatility 2.53% 2.70%
Perf 5Y 15.23%
Dividend TTM 9.26 (3.14%)
EV/Sales 6.11
EPS Y/Y TTM 56.99%
Oper. Margin 26.26%
ATR (14) 7.53
Perf 10Y 92.66%
Dividend Ex-Date May 16, 2025
Quick Ratio 0.88
Sales Y/Y TTM 15.59%
Profit Margin 17.49%
RSI (14) 55.95
Recom 2.21
Dividend Gr. 3/5Y 8.53% 9.18%
Current Ratio 1.17
EPS Q/Q 1616.98%
SMA20 1.98%
Beta 0.48
Target Price 315.52
Payout 119.05%
Debt/Eq 9.24
Sales Q/Q 9.42%
SMA50 4.15%
Rel Volume 0.57
Prev Close 300.37
Employees 28000
LT Debt/Eq 8.70
Earnings May 01 AMC
SMA200 0.81%
Avg Volume 2.81M
Price 295.27
IPO Jun 17, 1983
Option/Short Yes / Yes
EPS/Sales Surpr. 14.76% 1.14%
Trades
Volume 1,611,237
Change -1.70%
Date
Action
Analyst
Rating Change
Price Target Change
May-20-25 Resumed
Guggenheim
Neutral
$288
Apr-22-25 Resumed
Cantor Fitzgerald
Neutral
$305
Dec-10-24 Resumed
BofA Securities
Underperform
$256
Nov-15-24 Initiated
Wolfe Research
Peer Perform
Nov-14-24 Initiated
Citigroup
Neutral
$335
Oct-17-24 Initiated
Bernstein
Outperform
$380
Oct-14-24 Downgrade
Truist
Buy → Hold
$320 → $333
Sep-27-24 Initiated
Cantor Fitzgerald
Overweight
$405
Aug-07-24 Downgrade
Wells Fargo
Overweight → Equal Weight
$320 → $335
May-03-24 Upgrade
William Blair
Mkt Perform → Outperform
May-03-24 Upgrade
Barclays
Underweight → Equal Weight
$230 → $300
Mar-28-24 Resumed
Raymond James
Mkt Perform
Feb-07-24 Downgrade
Leerink Partners
Outperform → Market Perform
$324 → $318
Dec-21-23 Upgrade
Daiwa Securities
Neutral → Buy
$264 → $320
Dec-19-23 Upgrade
BMO Capital Markets
Market Perform → Outperform
$286 → $326
Dec-12-23 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$256 → $300
Nov-09-23 Initiated
Deutsche Bank
Hold
$240
Nov-02-23 Upgrade
Truist
Hold → Buy
$260 → $320
Oct-20-23 Resumed
JP Morgan
Neutral
$265 → $270
Oct-17-23 Resumed
Morgan Stanley
Equal-Weight
$300
Show Previous Ratings
Jul-11-25 05:50PM
09:40AM
08:31AM
04:01AM
Jul-10-25 04:47PM
(Investor's Business Daily)
03:28PM
Loading…
03:28PM
(Investor's Business Daily)
10:09AM
09:04AM
(Investor's Business Daily)
04:21AM
Jul-09-25 09:50AM
Jul-08-25 06:00PM
04:01PM
02:27PM
02:17PM
Jul-06-25 03:35AM
03:22AM
Loading…
Jul-04-25 03:22AM
01:01AM
Jul-03-25 06:36AM
02:47AM
Jul-02-25 07:31PM
05:50PM
01:34PM
09:07AM
09:00AM
Jul-01-25 09:14PM
06:55PM
06:09PM
12:11PM
09:00AM
05:32AM
04:05PM
Loading…
Jun-30-25 04:05PM
(Investor's Business Daily)
09:00AM
06:20AM
05:05AM
Jun-28-25 12:20PM
Jun-27-25 11:10AM
10:10AM
09:45AM
09:35AM
Jun-26-25 11:12AM
04:02AM
Jun-25-25 05:50PM
09:40AM
Jun-24-25 02:07PM
11:49AM
11:00AM
07:52AM
Jun-23-25 09:57PM
(Morningstar Research) -5.84%
06:00PM
04:53PM
04:15PM
03:49PM
02:31PM
02:30PM
02:30PM
(Investor's Business Daily)
12:51PM
(Investor's Business Daily)
09:22AM
Jun-20-25 09:00AM
Jun-18-25 10:49PM
10:52AM
09:00AM
Jun-17-25 11:20AM
09:33AM
Jun-16-25 11:13PM
12:35PM
09:00AM
06:36AM
(Pharmaceutical Technology)
Jun-15-25 05:38AM
Jun-13-25 10:41AM
09:47AM
09:00AM
Jun-12-25 05:50PM
Jun-11-25 09:50AM
09:38AM
Jun-10-25 08:24PM
09:45AM
Jun-09-25 11:15PM
11:08AM
09:40AM
09:00AM
06:20AM
Jun-06-25 01:31PM
(Investor's Business Daily)
06:45AM
Jun-05-25 04:01PM
01:58PM
11:28AM
Jun-04-25 10:31AM
05:52AM
Jun-03-25 09:43AM
Jun-02-25 01:38PM
09:10AM
08:04AM
07:00AM
May-30-25 04:01PM
May-29-25 04:45AM
May-27-25 10:18PM
11:19AM
09:00AM
May-26-25 09:10AM
May-24-25 07:15AM
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Khosla Rachna SVP, Business Development Jun 05 '25 Sale 289.68 1,500 434,520 8,162 Jun 06 07:49 PM Khosla Rachna Officer Jun 05 '25 Proposed Sale 290.00 1,500 435,000 Jun 05 12:24 PM Busch Matthew C. VP, Finance & CAO May 02 '25 Sale 279.69 1,000 279,690 4,034 May 06 08:07 PM Busch Matthew C. Officer May 02 '25 Proposed Sale 281.44 1,000 281,440 May 02 02:37 PM Santos Esteban EVP, Operations Feb 19 '25 Option Exercise 156.35 8,711 1,361,965 80,257 Feb 21 08:07 PM Santos Esteban EVP, Operations Feb 19 '25 Sale 292.84 8,711 2,550,903 71,546 Feb 21 08:07 PM REESE DAVID M EVP & Chief Technology Officer Feb 19 '25 Option Exercise 156.35 8,711 1,361,965 70,858 Feb 21 08:06 PM REESE DAVID M EVP & Chief Technology Officer Feb 21 '25 Sale 304.44 25,225 7,679,524 36,922 Feb 21 08:06 PM REESE DAVID M EVP & Chief Technology Officer Feb 19 '25 Sale 293.22 8,711 2,554,224 62,147 Feb 21 08:06 PM DAVID M REESE & JOAN I CHUCO-T Officer Feb 21 '25 Proposed Sale 304.44 25,225 7,679,524 Feb 21 04:27 PM Miller Derek SVP, Human Resources Feb 19 '25 Option Exercise 156.35 1,524 238,277 10,068 Feb 20 08:59 PM Miller Derek SVP, Human Resources Feb 19 '25 Sale 293.74 1,524 447,655 8,544 Feb 20 08:59 PM Miller Derek SVP, Human Resources Feb 18 '25 Sale 292.56 500 146,279 8,544 Feb 20 08:59 PM DEREK MILLER Officer Feb 19 '25 Proposed Sale 293.74 1,524 447,655 Feb 19 04:18 PM DAVID REESE Officer Feb 19 '25 Proposed Sale 293.22 8,711 2,554,224 Feb 19 04:14 PM Santos Esteban Affiliate Feb 19 '25 Proposed Sale 292.11 8,711 2,544,570 Feb 19 02:25 PM DEREK MILLER Officer Feb 18 '25 Proposed Sale 292.56 500 146,279 Feb 18 04:10 PM Gordon Murdo EVP, Global Commercial Ops Feb 11 '25 Sale 294.79 8,771 2,585,644 44,186 Feb 13 09:02 PM Gordon Murdo Officer Feb 11 '25 Proposed Sale 295.30 8,771 2,590,076 Feb 11 03:01 PM Graham Jonathan P EVP & Gen. Counsel & Secy. Feb 07 '25 Option Exercise 156.35 25,045 3,915,786 54,032 Feb 10 09:52 PM Graham Jonathan P EVP & Gen. Counsel & Secy. Feb 07 '25 Sale 293.12 25,045 7,341,123 28,987 Feb 10 09:52 PM Graham Jonathan P Officer Feb 07 '25 Proposed Sale 292.94 25,045 7,336,682 Feb 07 03:05 PM Grygiel Nancy A. SVP & CCO Feb 05 '25 Sale 304.47 1,589 483,808 7,210 Feb 06 08:54 PM Grygiel Nancy A. Officer Feb 05 '25 Proposed Sale 304.47 1,589 483,800 Feb 05 12:53 PM